Scinai Immunotherapeutics (SCNI) Other financing activities (2020 - 2026)
Scinai Immunotherapeutics (SCNI) reported Other financing activities of $151000.0 for Q1 2026, up 15.27% on a YoY basis from $131000.0 in Q1 2025, and up 1272.73% sequentially from $11000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Other financing activities (2020 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 6 years of Other financing activities data on file, last reported at $151000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 15.27% year-over-year to $151000.0; the trailing twelve-month figure through Mar 2026 stood at $293000.0 (up 94.04% YoY), and the FY2024 full-year result was $1.4 million, up 52.16% from the prior year.
- Other financing activities rose to $151000.0 in Q1 2026, from $11000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $5.7 million in Q4 2022 to a low of -$4000.0 in Q3 2023.
- A 5-year average of $698916.7 and a median of $69500.0 in 2023 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities slumped 300.0% in 2023 and surged 1300.0% in 2024, its largest moves.
- Tracing SCNI's Other financing activities over 5 years: stood at $5.7 million in 2022, then sank by 85.54% to $825000.0 in 2023, then tumbled by 99.03% to $8000.0 in 2024, then jumped by 37.5% to $11000.0 in 2025, then soared by 1272.73% to $151000.0 in 2026.
- Business Quant data shows SCNI's Other financing activities at $151000.0 in Q1 2026, $11000.0 in Q2 2025, and $131000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 131,000.00 |
| Mar 31, 2025 | 131,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 825,000.00 |
| Dec 31, 2023 | 825,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Mar 31, 2023 | 127,000.00 |